204 - Rigosertib in Combination with Azacitidine Modulates Epigenetic Pathways and can Overcome Clinical Resistance to Hypomethylating Agents in Myelodysplastic Syndromes (MDS)
| Autor: | Chaurasia, P., Isoda, F., Navada, S., Odchimar-Reissig, R., Demakos, E.P., Reddy, E.P., Silverman, L.R. |
|---|---|
| Zdroj: | In Leukemia Research April 2017 55 Supplement 1:S121-S121 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect